Ann Surg

1. KIM J, Asselmann D, Wolf T, Kong SH, et al
   Automated Assessment of Surgical Quality in Distal Gastrectomy: Development of a Novel Computer Vision Model Based on the Critical View of Quality (CVQ).
   Ann Surg. 2026;284:607-617.
   

   >> Share

   
   

   
   Clin Cancer Res

2. WAINBERG ZA, Anghel A, Desai AJ, Ayala R, et al
   Editor's Note: Lapatinib, a Dual EGFR and HER2 Kinase Inhibitor, Selectively Inhibits HER2-Amplified Human Gastric Cancer Cells and is Synergistic with Trastuzumab In vitro and In vivo.
   Clin Cancer Res. 2026;32:3707.
   

   >> Share

   
   

   
   Clin Med Insights Oncol

3. SULEIMENOV Y, Samigatova A, Seksenbayev B, Altaeva N, et al
   Molecular Mechanisms and Biomarkers Driving the Transition From Chronic Atrophic Gastritis to Gastric Cancer.
   Clin Med Insights Oncol. 2026;20:11795549261478177.
   

   >> Share

   
   

   
   Dig Dis Sci

4. KIM GH
   Metachronous Gastric Cancer After Endoscopic Submucosal Dissection in Helicobacter pylori-Uninfected Patients: Time to Individualize Surveillance?
   Dig Dis Sci. 2026 Aug 9. doi: 10.1007/s10620-026-10162.
   

   >> Share

   
   

   
   Endoscopy

5. ANDRADE A, Ribeiro AR, Bezerra J, Ribeiro H, et al
   When monopolar electrosurgery is not an option - successful bipolar endoscopic submucosal dissection for early gastric cancer.
   Endoscopy. 2026 Aug 14. doi: 10.1055/a-2928-8240.
   

   >> Share

   
   
6. PARK JS, Lee EA, Park JH, Park B, et al
   Long-term risk of metachronous gastric neoplasms after curative endoscopic submucosal dissection for early gastric cancer.
   Endoscopy. 2026 Aug 10. doi: 10.1055/a-2936-0365.
   

   >> Share

   
   

   
   Gastrointest Endosc

7. LIU L, Liu Z, Yao X
   Optimal gastric cancer screening intervals: risk stratification and clinical considerations.
   Gastrointest Endosc. 2026;104:492.
   

   >> Share

   
   
8. YIP HC, Uedo N, Iwagami H, Waki K, et al
   The use of diluted epinephrine during gastric endoscopic submucosal dissection: an international randomized controlled trial.
   Gastrointest Endosc. 2026;104:387-395.
   

   >> Share

   
   

   
   J Clin Oncol

9. NAKAYAMA I, Ryu MH, Lim SH, Kim JG, et al
   EP4 Antagonist ONO-4578 Plus Nivolumab and Chemotherapy in Human Epidermal Growth Factor Receptor 2-Negative Unresectable Advanced or Recurrent Gastric or Gastroesophageal Junction Cancer.
   J Clin Oncol. 2026;44:2198-2210.
   

   >> Share

   
   

   
   J Gastroenterol Hepatol

10. RAZA F, Jabbar D, Ullah FNUM, Khan M, et al
    Re: "Differences in the Gastric Microbiotas of Neighboring Populations With Divergent Risks of Gastric Cancer" by Caguazango et al.
    J Gastroenterol Hepatol. 2026 Aug 13. doi: 10.1111/jgh.70665.
    

    >> Share

    
    

    
    J Surg Oncol

11. GUPTA A, Desai M, Perwaiz A, Sharma V, et al
    Muscle Quantity Meets Muscle Quality: Integrating Skeletal Muscle Index and Hand Grip Strength to Predict Surgical Risk in Esophago-Gastric Cancer.
    J Surg Oncol. 2026 Aug 10. doi: 10.1002/jso.70370.
    

    >> Share

    
    

    
    PLoS One

12. KANKAYA S, Karatas M, Hatipoglu E, Kepil N, et al
    A comparative study of CDO1 promoter methylation in gastric cancer and H. pylori-associated chronic gastritis: Implications for diagnostic performance.
    PLoS One. 2026;21:e0335832.
    

    >> Share

    
    
13. DONG Y, Luo P, Chai L, Li X, et al
    Effects of high CD93 expression on tumor growth and angiogenesis in gastric adenocarcinoma.
    PLoS One. 2026;21:e0355284.
    

    >> Share

    
    

Free Medical Abstracts
Privacy Policy
Sponsors
Share